Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.46 USD | -1.36% | -4.87% | -6.81% |
12/04 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
04/04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 625M 52.15B |
---|---|---|---|---|---|
Net income 2024 * | -89M -7.43B | Net income 2025 * | -99M -8.26B | EV / Sales 2024 * | - |
Net cash position 2024 * | 63.08M 5.26B | Net Debt 2025 * | 6.79M 567M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.19
x | P/E ratio 2025 * |
-7.1
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
1 day | -1.36% | ||
1 week | -4.87% | ||
Current month | -28.68% | ||
1 month | -31.41% | ||
3 months | +16.55% | ||
6 months | +111.32% | ||
Current year | -6.81% |
Managers | Title | Age | Since |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 27/18/27 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/21/01 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 19/23/19 |
Maha Katabi
BRD | Director/Board Member | 50 | 01/20/01 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01/21/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 21.2 | -2.53% | 9 378 |
26/24/26 | 21.75 | +0.83% | 74,007 |
25/24/25 | 21.57 | +1.75% | 119,830 |
24/24/24 | 21.2 | -8.70% | 304,305 |
23/24/23 | 23.22 | +4.74% | 148,258 |
Delayed Quote Nasdaq, April 29, 2024 at 08:33 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.81% | 625M | |
+2.20% | 42.75B | |
+47.81% | 41.61B | |
+12.46% | 41.34B | |
-12.36% | 26.59B | |
+8.71% | 25.49B | |
-23.55% | 18.12B | |
+30.90% | 12.24B | |
-1.85% | 11.76B | |
+8.47% | 11B |
- Stock Market
- Equities
- AVTE Stock